ClassID:

97028

C07K14/705 - page 7 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans Receptors; Cell surface antigens; Cell surface determinants

Recent Application in this class:
#1801
20170096493
2017-04-06

Anti human Notch4 antibody

#1802
20170088858
2017-03-30

Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor

#1803
20170088620
2017-03-30

Methods of treating cardiovascular disease with an ASGR inhibitor

#1804
20170081405
2017-03-23

Mesothelin-targeted chimeric antigen receptors and uses thereof

#1805
20170081387
2017-03-23

Fusion protein inhibiting TACI-BAFF complex formation and preparation method therefor and use thereof

#1806
20170081384
2017-03-23

Targeted delivery of glycine receptors to excitable cells

#1807
20170080050
2017-03-23

Optically-based stimulation of target cells and modifications thereto

#1808
20170073389
2017-03-16

Sfrp5-derived peptide fragment and cosmetic composition for skin whitening containing same

#1809
20170072037
2017-03-16

Xenoantigen-displaying anti-cancer vaccines and method of making

#1810
20170067909
2017-03-09

ASSAY-READY RECOMBINANT CELLS TRANSIENTLY OVEREXPRESSING GENES ENCODING DRUG TRANSPORTER PROTEINS AND/OR DRUG METABOLIZING ENZYMES

#1811
20170066820
2017-03-09

Antibodies specific for sulfation sites of sclerostin

#1812
20170066799
2017-03-09

Stitched polypeptides

#1813
20170066505
2017-03-09

Device for mooring a water craft to a mooring berth of a pontoon, and corresponding pontoon

#1814
20170059570
2017-03-02

Method and biomarker for detecting metastasis of sarcoma

#1815
20170058041
2017-03-02

Methods of reducing clinical symptoms of viral infection by administering a toll-like receptor 3 antagonist

#1816
20170058028
2017-03-02

APLNR modulators and uses thereof

#1817
20170058016
2017-03-02

Variants derived from ActRIIB and uses therefor

#1818
20170056518
2017-03-02

Pharmaceuticals in joint-linker configurations for treating pathological blood clots

#1819
20170056470
2017-03-02

Peptides of syndecan-1 for inhibiting angiogenesis

#1820
20170056467
2017-03-02

Optically-based stimulation of target cells and modifications thereto

#1821
20170051255
2017-02-23

Vesicular stomatitis viruses

#1822
20170051035
2017-02-23

Compositions and methods of chimeric autoantibody receptor T cells

#1823
20170049910
2017-02-23

Enhanced AAV-mediated gene transfer for retinal therapies

#1824
20170049818
2017-02-23

Methods for off-the-shelf-tumor immunotherapy using allogeneic T-cell precursors

#1825
20170044232
2017-02-16

MUTANT SMOOTHENED AND METHODS OF USING THE SAME

#1826
20170044220
2017-02-16

EXPRESSION OF TRIPLE-HELICAL COLLAGEN-LIKE PRODUCTS IN E.COLI

#1827
20170042967
2017-02-16

TREATMENT OF COMPLEMENT-ASSOCIATED DISORDERS

#1828
20170037110
2017-02-09

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#1829
20170037107
2017-02-09

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#1830
20170037098
2017-02-09

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#1831
20170037097
2017-02-09

Peptides and combination of peptides for use in immunotherapy against non-small cell lung cancer and other cancers

#1832
20170037096
2017-02-09

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#1833
20170037095
2017-02-09

Method for treating cancer with an activated T lymphocyte that selectively recognizes a cancer cell consisting of specific peptide

#1834
20170037094
2017-02-09

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#1835
20170037093
2017-02-09

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#1836
20170037092
2017-02-09

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#1837
20170028082
2017-02-02

Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor

#1838
20170022520
2017-01-26

Muller cell-specific promoter

#1839
20170022263
2017-01-26

Tumor targeted TNF-related apoptosis inducing ligand fusion polypeptide, methods and uses therefor

#1840
20170022261
2017-01-26

Oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same

#1841
20170022251
2017-01-26

Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers

#1842
20170016912
2017-01-19

Human biosensors for detecting voltage changes

#1843
20170016026
2017-01-19

Chimeric nucleic acid molecules with non-AUG translation initiation sequences and uses thereof

#1844
20170014508
2017-01-19

Chimeric antigen receptor (CAR) signalling system

#1845
20170014476
2017-01-19

SorCS1 for the treatment of obesity

#1846
20170010257
2017-01-12

Human biosensors for detecting ATP

#1847
20170009259
2017-01-12

Transformant for expressing cis-prenyltranferase and Nogo B receptor

#1848
20170008946
2017-01-12

Mimetic peptides which modulate L-type calcium channels

#1849
20170007687
2017-01-12

Peptide vaccine therapy for treatment of FRα-expressing tumors

#1850
20170002320
2017-01-05

Protein markers associated bone marrow stem cell differentiation into early progentior cells

#1851
20170002072
2017-01-05

Compositions and methods for treating cancer

#1852
20170002053
2017-01-05

Cold- and menthol-sensitive receptor (CMR1)

#1853
20170002050
2017-01-05

EphA2 T-cell epitope agonists and uses therefore

#1854
20170002043
2017-01-05

Peptides and methods and uses thereof for preventing retinal disorders

#1855
20170000827
2017-01-05

Brown adipocyte modification

#1856
20160376655
2016-12-29

TRPC6 involved in glomerulonephritis

#1857
20160376340
2016-12-29

Diagnosis and therapy of multiple sclerosis

#1858
20160376338
2016-12-29

Heat-sensing protein switches and uses thereof

#1859
20160368967
2016-12-22

Methods and compositions for the inhibition of TRPV4

#1860
20160368963
2016-12-22

TENEURIN C-TERMINAL ASSOCIATED PEPTIDES (TCAP) AND METHODS AND USES THEREOF

#1861
20160367652
2016-12-22

Chimeric nucleic acid molecules with non-AUG translation initiation sequences and uses thereof

#1862
20160356776
2016-12-08

Methods and Compositions for Detecting Botulinum Neurotoxin

#1863
20160355828
2016-12-08

Organic compounds

#1864
20160355568
2016-12-08

Recombinant factor VIII proteins

#1865
20160355565
2016-12-08

Diagnosis of a neuroautoimmune disease comprising measuring autoantibodies to flotillin1 and/or flotillin2

#1866
20160354488
2016-12-08

AAV-mediated subcellular targeting of heterologous rhodopsins in retinal ganglion cells

#1867
20160354465
2016-12-08

Methods for Treating Pressure Induced Optic Neuropathy, Preventing Neuronal Degeneration and Promoting Neuronal Cell Survival Via Administration of Lingo-1 Antagonists and TrkB Agonists

#1868
20160354455
2016-12-08

Chimeric nucleic acid molecules with non-AUG translation initiation sequences and uses thereof

#1869
20160353721
2016-12-08

Sperm-Specific Cation Channel, Catsper3, and Uses Therefor

#1870
20160353720
2016-12-08

SPERM-SPECIFIC CATION CHANNEL, CATSPER4, AND USES THEREFOR

#1871
20160347858
2016-12-01

Anti human Notch4 antibody

#1872
20160347842
2016-12-01

Protein binding domains stabilizing functional conformational states of GPCRs and uses thereof

#1873
20160347815
2016-12-01

Peptide mimotopes of claudin 18.2 and uses thereof

#1874
20160347814
2016-12-01

VSTM5 POLYPEPTIDES AND USES THEREOF AS A DRUG FOR TREATMENT OF CANCER, INFECTIOUS DISEASES AND IMMUNE RELATED DISEASES

#1875
20160346391
2016-12-01

Compositions and methods to modulate cell activity

#1876
20160346368
2016-12-01

Immunotherapy with binding agents

#1877
20160340402
2016-11-24

FKBP-L polypeptides and uses in angiogenesis-mediated disorders

#1878
20160340401
2016-11-24

FKBP-L AND USES THEREOF

#1879
20160340399
2016-11-24

Tumor necrosis factor (TNF) family ligand trimer-containing antigen binding molecules

#1880
20160333098
2016-11-17

Class of monospecific and bispecific humanized antibodies that target the insulin-like growth factor type I receptor (IGF-1R)

#1881
20160333071
2016-11-17

Biological Pacemakers Incorporating HCN2 and SkM1 Genes

#1882
20160333070
2016-11-17

Pro-angiogenic peptides and peptide conjugates

#1883
20160333069
2016-11-17

System and method for controlling G-protein coupled receptor pathways

#1884
20160331805
2016-11-17

Treatment of ocular disorders with anti-connexin proteins and mimetics

#1885
20160327576
2016-11-10

Methods for screening for binding partners of G-protein coupled receptors

#1886
20160324987
2016-11-10

USE OF CRISPR/CAS9 AS IN VIVO GENE THERAPY TO GENERATE TARGETED GENOMIC DISRUPTIONS IN GENES BEARING DOMINANT MUTATIONS FOR RETINITIS PIGMENTOSA

#1887
20160319253
2016-11-03

NOVEL FUSION GENES AS FACTORS RESPONSIBLE FOR GASTRIC CANCER

#1888
20160319034
2016-11-03

MET-BINDING AGENTS AND USES THEREOF

#1889
20160318975
2016-11-03

Method for promoting expression of calreticulin, and synthetic peptide for use in method for promoting expression of calreticulin

#1890
20160318974
2016-11-03

Method of loading a crystallization device

#1891
20160317667
2016-11-03

Etanercept formulations stabilized with xylitol

#1892
20160317616
2016-11-03

Pharmaceutical compositions targeting WNT pathway proteins

#1893
20160313354
2016-10-27

Mutant smoothened and methods of using the same

#1894
20160313305
2016-10-27

Methods of identifying modulators of olfactory receptors

#1895
20160311900
2016-10-27

Plexin D1 as a target for tumor diagnosis and therapy

#1896
20160311875
2016-10-27

Peptide and application thereof

#1897
20160310754
2016-10-27

SYSTEMS AND METHODS FOR CONTROLLING ANIMAL BEHAVIOR VIA OPTOGENETICS

#1898
20160310583
2016-10-27

TUMOR ANTIGEN PEPTIDE

#1899
20160305970
2016-10-20

CELL LINES AND METHODS FOR MAKING AND USING THEM

#1900
20160305940
2016-10-20

Peptide substrates recognizable by type E botulinum neurotoxin

#1901
20160304904
2016-10-20

Directed evolution and in vivo panning of virus vectors

#1902
20160304577
2016-10-20

GLYCOSYLATED GLYCOPHORIN PEPTIDES

#1903
20160304560
2016-10-20

PAR4 agonist peptides

#1904
20160303192
2016-10-20

Optically-controlled CNS dysfunction

#1905
20160302398
2016-10-20

Animal model and method for studying gene-gene interactions

#1906
20160297863
2016-10-13

EPHA3 And multi-valent targeting of tumors

#1907
20160289731
2016-10-06

MEANS AND METHODS FOR DETERMINATION OF BOTULINUM NEUROTOXIN BIOLOGICAL ACTIVITY

#1908
20160289316
2016-10-06

Antibodies that specifcally bind Sost and Wise peptides

#1909
20160289296
2016-10-06

Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers

#1910
20160289292
2016-10-06

ALK4:ActRIIB heteromultimers and uses thereof

#1911
20160287687
2016-10-06

Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers

#1912
20160272708
2016-09-22

Anti-PD-1 antibody and use thereof

#1913
20160266095
2016-09-15

Method for identifying modulators of notch signaling

#1914
20160264961
2016-09-15

Protease-resistant systems for polypeptide display and methods of making and using thereof

#1915
20160264665
2016-09-15

Binding-triggered transcriptional switches and methods of use thereof

#1916
20160264641
2016-09-15

Consumable cryopreserved cells transiently overexpressing gene(s) encoding drug transporter protein(s) and/or drug metabolizing enzyme(s)

#1917
20160264640
2016-09-15

Water soluble membrane proteins and methods for the preparation and use thereof

#1918
20160256560
2016-09-08

Environmentally sensitive compositions and methods of use thereof

#1919
20160256525
2016-09-08

Muteins of tear lipocalin and methods for obtaining the same

#1920
20160252524
2016-09-01

Light-activated cation channel and uses thereof

#1921
20160244501
2016-08-25

Polynucleotides encoding low density lipoprotein receptor

#1922
20160237153
2016-08-18

Na1.7 antibodies and methods of using the same

#1923
20160237136
2016-08-18

NOVEL CELL LINES EXPRESSING ENaC and METHODS USING THEM

#1924
20160235844
2016-08-18

METHODS OF TREATING NEUROENDOCRINE TUMORS USING FRIZZLED-BINDING AGENTS

#1925
20160235829
2016-08-18

Vectors for expression of prostate-associated antigens

#1926
20160231316
2016-08-11

Nanovesicle comprising heterodimeric G-protein coupled receptor, method for preparing nanovesicle, field effect transistor-based taste sensor comprising nanovesicle, and method for manufacturing taste sensor

#1927
20160230228
2016-08-11

Compositions and methods for detecting and treating neurological conditions

#1928
20160229892
2016-08-11

Cyclic peptide conjugates and methods of use

#1929
20160229794
2016-08-11

Photoreactive synthetic regulator of protein function and methods of use thereof

#1930
20160220672
2016-08-04

Sonogenic stimulation of cells

#1931
20160215048
2016-07-28

IL-18 binding protein (IL-18BP) in inflammatory diseases

#1932
20160215038
2016-07-28

Soluble CD33 for treating myelodysplastic syndromes (MDS)

#1933
20160210400
2016-07-21

STING crystals and modulators

#1934
20160209430
2016-07-21

Methods for increasing palatability of pet foodstuff

#1935
20160207999
2016-07-21

Anti-human folate receptor beta antibodies and methods of use

#1936
20160206754
2016-07-21

Molecular constructs for treating tumors

#1937
20160201088
2016-07-14

Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor

#1938
20160200813
2016-07-14

LRP-8 binding dual variable domain immunoglobulin proteins

#1939
20160199489
2016-07-14

Etanercept formulations stabilized with combinations of sugars and polyols

#1940
20160199442
2016-07-14

Anti-P2Xpeptides and epitopes

#1941
20160195539
2016-07-07

Identification of tumor-associated cell surface antigens for diagnosis and therapy

#1942
20160195513
2016-07-07

Evaluation method and screening method for sphingosine-1-phosphate 1 (S1P1) receptor agonists

#1943
20160194374
2016-07-07

Recombinant AAV-crumbs homologue composition and methods for treating LCA-8 and progressive RP

#1944
20160194312
2016-07-07

Activation of TRPV4 ion channel by physical stimuli and critical role for TRPV4 in organ-specific inflammation and itch

#1945
20160193309
2016-07-07

Method to generate antibodies to ion channels

#1946
20160193290
2016-07-07

Methods of reducing myocardial injury following myocardial infarction

#1947
20160193289
2016-07-07

Molecular signature of cancer

#1948
20160193288
2016-07-07

Therapeutic TREM-1 peptides

#1949
20160187322
2016-06-30

Feline bitter taste receptors and methods

#1950
20160185862
2016-06-30

Chimeric antigen receptor and methods of use thereof

#1951
20160185838
2016-06-30

Methods of treating cancer by administering a soluble receptor comprising a human Fc domain and the Fri domain from human frizzled receptor

#1952
20160184455
2016-06-30

COMPOSITIONS AND METHODS FOR TREATING SMOOTH MUSCLE DYSFUNCTION

#1953
20160178616
2016-06-23

In vitro method using hetero-oligomeric T1R1/T1R3 taste receptors to identify umami tastants

#1954
20160177318
2016-06-23

Selection vectors and methods of selecting eukaryotic host cells

#1955
20160176933
2016-06-23

Mutant channelrhodopsins with altered ion selectivity

#1956
20160168227
2016-06-16

COMPOSITION AND VACCINE FOR TREATING LUNG CANCER

#1957
20160166668
2016-06-16

COMPOSITION AND VACCINE FOR TREATING PROSTATE CANCER

#1958
20160166666
2016-06-16

TUMOR ANTIGEN PEPTIDE

#1959
20160161482
2016-06-09

Means and methods for diagnosing and treating multiple sclerosis

#1960
20160159881
2016-06-09

High affinity NY-ESO T cell receptors

#1961
20160159879
2016-06-09

REGULATION OF SODIUM CHANNELS BY PLUNC PROTEINS

#1962
20160159878
2016-06-09

NOGO Receptor Antagonists

#1963
20160158385
2016-06-09

Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins

#1964
20160158357
2016-06-09

Methods of treating anaemia

#1965
20160157470
2016-06-09

Non-human animals having a humanized cluster of differentiation 47 gene

#1966
20160151516
2016-06-02

Modified polynucleotides for the production of proteins

#1967
20160151466
2016-06-02

Botulinum neurotoxins with modified light chain specificity and methods for producing same

#1968
20160151452
2016-06-02

Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof

#1969
20160145641
2016-05-26

STEPWISE DIFFERENTIATION OF STEM CELLS FOR THE PRODUCTION OF EUKARYOTIC MEMBRANE PROTEINS

#1970
20160138043
2016-05-19

Retinal on bipolar cells-specific artificial promoter

#1971
20160137745
2016-05-19

Methods for treating patients with heterozygous familial hypercholesterolemia (heFH) with an anti-PCSK9 antibody

#1972
20160137716
2016-05-19

Therapeutic delivery vesicles

#1973
20160137714
2016-05-19

PEPTIDES WITH ENHANCED STABILITY AND THEIR USE IN METHODS FOR TREATING DISEASES

#1974
20160137713
2016-05-19

FcRn-specific human antibody and composition for treatment of autoimmune diseases

#1975
20160136236
2016-05-19

Compositions and Methods of Altering Cholesterol Levels

#1976
20160131638
2016-05-12

Immunity to folate receptors

#1977
20160130567
2016-05-12

MESSENGER UNA MOLECULES AND USES THEREOF

#1978
20160130357
2016-05-12

Compositions comprising chimeric antigen receptors, T cells comprising the same, and methods of using the same

#1979
20160130342
2016-05-12

Methods of treating cancer with antibodies that bind P2X7 receptors

#1980
20160123956
2016-05-05

Modified membrane spanning proteins and methods for the preparation and use thereof

#1981
20160122412
2016-05-05

Composition comprised of antigen linked to a TNF superfamily ligand

#1982
20160120933
2016-05-05

Inhibitors of mitochondrial fission and methods of use thereof

#1983
20160115217
2016-04-28

COMPOSITIONS OF HUMANIZED NOTCH FUSION PROTEINS AND METHODS OF TREATMENT

#1984
20160114017
2016-04-28

Methods for treating brain cancer using il-13r alpha 2 peptide-based compositions

#1985
20160109454
2016-04-21

Disease-associated antigens and methods of use thereof

#1986
20160108087
2016-04-21

Therapeutics for the induction of endogenous steroidogenesis and methods associated with their identification

#1987
20160106772
2016-04-21

CFTR mRNA compositions and related methods and uses

#1988
20160102132
2016-04-14

Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T-cells

#1989
20160102131
2016-04-14

Consumable cryopreserved cells transiently overexpressing gene(s) encoding drug transporter protein(s) and/or drug metabolizing enzyme(s)

#1990
20160102130
2016-04-14

Water soluble G-protein coupled receptor

#1991
20160096036
2016-04-07

Implantable prosthetic device comprising a cell expressing a channelrhodopsin

#1992
20160095896
2016-04-07

Bis-sulfhydryl macrocyclization systems

#1993
20160095837
2016-04-07

MODULATION OF MITOCHONDRIAL CALCIUM UNIPORTER ACTIVITY FOR TREATING AND PREVENTING ARRHYTHMIAS

#1994
20160091488
2016-03-31

Methods of using U2-OS cells to identify potential sweet taste modulators

#1995
20160084834
2016-03-24

Taste receptor internalization assay

#1996
20160082079
2016-03-24

Wnt antagonist and methods of treatment and screening

#1997
20160082046
2016-03-24

In vitro production of red blood cells with proteins comprising sortase recognition motifs

#1998
20160081314
2016-03-24

Chimeric Antigen Receptors

#1999
20160077113
2016-03-17

Methods of Identifying Candidate Compounds of the Human G Protein-Coupled Receptor, GPR50, as Modulators of Body Mass or Adiposity

#2000
20160076054
2016-03-17

Effective delivery of large genes by dual AAV vectors

#2001
20160075772
2016-03-17

Treatment of Fibrodysplasia Ossificans Progressiva

#2002
20160075752
2016-03-17

B-TYPE PLEXIN ANTAGONISTS AND USES THEREOF

#2003
20160075733
2016-03-17

Modified polynucleotides for the production of biologics and proteins associated with human disease

#2004
20160069868
2016-03-10

Methods of identifying compounds for the treatment of fibrosis by using S1PR5

#2005
20160069866
2016-03-10

INHIBITION OF THE BETA3 SUBUNIT OF L-TYPE CA2+ CHANNELS

#2006
20160068596
2016-03-10

Notch pathway inhibition

#2007
20160067355
2016-03-10

Composition for delivery of genetic material

#2008
20160061847
2016-03-03

T2R taste receptors and genes encoding same

#2009
20160060360
2016-03-03

RAPID CLEARANCE OF ANTIGEN COMPLEXES USING NOVEL ANTIBODIES

#2010
20160058828
2016-03-03

Methods, uses and compositions of Tie2 agonists

#2011
20160053332
2016-02-25

Identification of tumour-associated cell surface antigens for diagnosis and therapy

#2012
20160053024
2016-02-25

Bruton's tyrosine kinase as anti-cancer drug target

#2013
20160047808
2016-02-18

Depletion of mouse cells for isolation of human cells

#2014
20160046724
2016-02-18

Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor

#2015
20160046689
2016-02-18

Antibodies to MICA and MICB proteins

#2016
20160046671
2016-02-18

Stabilized SOS1 peptides

#2017
20160045599
2016-02-18

Devices, systems and methods for optogenetic modulation of action potentials in target cells

#2018
20160039902
2016-02-11

Channelrhodopsin variants and uses thereof

#2019
20160039901
2016-02-11

Inhibitors of TLR signaling by targeting TIR domain interfaces

#2020
20160038578
2016-02-11

Fully human antibodies to high molecular weight-melanoma associated antigen and uses thereof

#2021
20160033478
2016-02-04

Use of GPR83 to identify pruritus-related substances

#2022
20160031961
2016-02-04

Methods and compositions using a Klotho-FGF23 fusion polypeptide

#2023
20160031942
2016-02-04

RHAMM binding peptides

#2024
20160024502
2016-01-28

Recombinant polypeptide production

#2025
20160024223
2016-01-28

Treating hepatitis B virus infections by administering receptor associated protein (RAP)

#2026
20160024178
2016-01-28

Compounds for treating neurodegenerative proteinopathies

#2027
20160024173
2016-01-28

Non-hemolytic LLO fusion proteins and methods of utilizing same

#2028
20160024172
2016-01-28

Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof

#2029
20160022841
2016-01-28

Method for augmenting vision in persons suffering from photoreceptor cell degeneration

#2030
20160015778
2016-01-21

SorCS1-like agent for use in the treatment of insulin resistance and diseases related thereto

#2031
20160015775
2016-01-21

Lipopeptides for use in treating liver diseases and cardiovascular diseases

#2032
20160015062
2016-01-21

Feline bitter taste receptors and methods

#2033
20160010155
2016-01-14

KCNK3 Channel Loss-of-Function Mutants in Familial and Idiopathic Pulmonary Arterial Hypertension

#2034
20160010134
2016-01-14

Assay for inhibitors of equilibrative or concentrative nucleoside transporters

#2035
20160009816
2016-01-14

Membrane transporter NaPi2b (SCL34A2) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy

#2036
20160009807
2016-01-14

Fusion immunomodulatory proteins and methods for making same

#2037
20160009780
2016-01-14

Gene Expression Control DNA Element and Associated Protein

#2038
20160003852
2016-01-07

Feline bitter taste receptors and methods

#2039
20160002725
2016-01-07

Use of TRPC6 mRNA levels in peripheral blood cells for early detection/diagnosis of senile dementia

#2040
20160002323
2016-01-07

Notch inhibition in the prevention of vein graft failure

#2041
20160002293
2016-01-07

Methods for the treatment of mitochondrial diseases associated with a mutation in or gene resulting in a disruption of mitochondrial oxidative phosphorylation

#2042
20150377818
2015-12-31

Biosensor incorporating protein-immobilized membrane and method of immobilizing protein in biosensor

#2043
20150376648
2015-12-31

In vivo production of proteins

#2044
20150376261
2015-12-31

Chimeric polypeptides comprising G protein-coupled receptors and VHH antibodies

#2045
20150376240
2015-12-31

Enhanced AAV-mediated gene transfer for retinal therapies

#2046
20150374810
2015-12-31

TOMM34 peptides and vaccines including the same

#2047
20150370961
2015-12-24

Water-soluble trans-membrane proteins and methods for the preparation and use thereof

#2048
20150369819
2015-12-24

TMEM120A ion channel modulator

#2049
20150369740
2015-12-24

Optogenetic probes for measuring membrane potential

#2050
20150368306
2015-12-24

Acid-resistant yeast cell with reduced FPS1 activity and method of producing lactate by using the yeast cell

#2051
20150366866
2015-12-24

Methods of treating cholangiocarcinoma

#2052
20150359842
2015-12-17

Pro-angiogenic fragments of prominin-1 and uses thereof

#2053
20150355200
2015-12-10

Method for selecting agents that bind to transmembrane receptors in a conformationally selective manner

#2054
20150352233
2015-12-10

Polypeptide and imaging method

#2055
20150352197
2015-12-10

PEPTIDE

#2056
20150344907
2015-12-03

Retinal OFF circuit-specific promoter

#2057
20150342993
2015-12-03

Compositions and methods for immunotherapy

#2058
20150337033
2015-11-26

Humanized or affinity-matured anti Ang-2 antibody and uses thereof

#2059
20150337009
2015-11-26

Toll-like receptor 2-agonistic lipopeptides, and method of making the same

#2060
20150329615
2015-11-19

NOTCH-BASED FUSION PROTEINS AND USES THEREOF

#2061
20150322447
2015-11-12

Soybean ROD1 gene sequences and uses thereof

#2062
20150322414
2015-11-12

Angiopoietin-2 specific TIE2 receptor

#2063
20150322141
2015-11-12

Phoenixin peptides

#2064
20150322132
2015-11-12

T1R taste receptors and genes encoding same

#2065
20150316552
2015-11-05

Human Notch Receptor Mutations and Their Use

#2066
20150315287
2015-11-05

Antibody to genetic products differentially expressed in tumors and the use thereof

#2067
20150315277
2015-11-05

Dual-target antibody targeting VEGFR-2 and DLL4, and pharmaceutical composition including same

#2068
20150315261
2015-11-05

Method for treating heart disease by inhibiting the Coxsackievirus-Adenovirus Receptor

#2069
20150313961
2015-11-05

Materials and Methods for Regulating Whole Body Glucose Homeostasis

#2070
20150307589
2015-10-29

PEPTIDIC ANTAGONISTS OF CLASS III SEMAPHORINS/NEUROPILINS COMPLEXES

#2071
20150307584
2015-10-29

Nucleic acids encoding a cold- and menthol-sensitive receptor

#2072
20150307583
2015-10-29

Reactivation of Axon Growth and Recovery in Chronic Spinal Cord Injury

#2073
20150307582
2015-10-29

Engineered receptors and their use

#2074
20150307581
2015-10-29

COMPOSITIONS AND METHODS FOR TREATING ANTIPHOSPHOLIPID SYNDROME

#2075
20150307556
2015-10-29

Template-fixed peptidomimetics with CXCR7 modulating activity

#2076
20150306141
2015-10-29

Method and compositions for cellular immunotherapy

#2077
20150299755
2015-10-22

METHODS AND COMPOSITIONS FOR IMPROVING SUGAR TRANSPORT, MIXED SUGAR FERMENTATION, AND PRODUCTION OF BIOFUELS

#2078
20150299322
2015-10-22

Agents that modulate immune cell activation and methods of use thereof

#2079
20150299293
2015-10-22

T1R taste receptors and genes encoding same

#2080
20150299292
2015-10-22

Methods and compositions for modulating Toso activity

#2081
20150299291
2015-10-22

cDNA-derived nucleic acids encoding red-shifted channelrhodopsins

#2082
20150299290
2015-10-22

IMMUNOGENIC VACCINE

#2083
20150299289
2015-10-22

Development of HBV-and/or HDV-susceptible cells, cell lines and non-human animals

#2084
20150299280
2015-10-22

MEDICAL TREATMENT USE OF CELL-MEMBRANE-PERMEABLE FIBROBLAST GROWTH FACTOR

#2085
20150291681
2015-10-15

METHODS AND COMPOSITIONS FOR MODULATING NOTCH ACTIVITY

#2086
20150291679
2015-10-15

Oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same

#2087
20150284798
2015-10-08

Compositions and Methods for the Diagnosis of Retinal Neovascularization

#2088
20150284444
2015-10-08

PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT INCLUDING FUSION PROTEIN

#2089
20150283226
2015-10-08

COMPOSITIONS AND METHODS OF MODULATING AN IMMUNE RESPONSE

#2090
20150276766
2015-10-01

BIOMARKER FOR USE IN TREATING ANEMIA

#2091
20150276749
2015-10-01

Method for detecting lung squamous cell carcinoma

#2092
20150276710
2015-10-01

Sweet taste receptor chimeric proteins and use thereof

#2093
20150274839
2015-10-01

Antibodies to non-functional P2X7 receptor

#2094
20150266956
2015-09-24

DC-STAMP antibodies

#2095
20150266955
2015-09-24

DETECTION AND TREATMENT OF NON-DERMAL FIBROSIS

#2096
20150260733
2015-09-17

Method for identifying compounds that modulate a T2R taste receptor

#2097
20150259395
2015-09-17

Compositions and methods for enhanced gene expression in cone cells

#2098
20150258186
2015-09-17

Chimeric nucleic acid molecule with non-AUG translation initiation sequences

#2099
20150253339
2015-09-10

NOVEL CELL LINES EXPRESSING NaV AND METHODS USING THEM

#2100
20150253326
2015-09-10

Methods and Compositions for Detecting Botulinum Neurotoxin